Among the most critical decisions for optimizing franchise value is pricing, which demands specialized expertise. Strategic Pricing groups in pharmaceutical and biotech companies cut through the institutional complexity to identify critical aspects of the portfolio strategy and support that strategy with sound pricing recommendations. Vice President Rhett Johnson discusses how an effective Strategic Pricing group possesses the regulatory knowledge, functional expertise, strategic vision, and portfolio-wide perspective to lead the organization toward maximum portfolio value. To read this article, click here:
Patent damages: Recent trends in Rule 702 decisions
Rule 702 decision trends are based on our review of available US district court decisions concerning damages experts in patent infringement matters that have...